top of page

Target

Our focus is on nurturing startups that integrate artificial intelligence, decentralised clinical trials, and digital therapeutic solutions into the healthcare landscape. By providing capital and strategic guidance, we empower these companies to revolutionise patient care, research, and drug development.

 

Our investments aim to streamline medical processes, enhance diagnostic precision, and personalise treatment, ultimately advancing the medical field and improving patient outcomes.

​

Our commitment extends beyond financial support; we foster a collaborative ecosystem where pioneering startups, particularly those delving into AI breakthroughs and innovative health platforms, can thrive. By backing these ventures, we contribute to the development of groundbreaking therapies and digital health solutions, ensuring they meet regulatory standards and reach patients faster.

 

ballas invest is dedicated to addressing high unmet needs, supporting visionary entrepreneurs across Europe, and investing in the future of medicine to create a healthier future for all.

someone using robotic legs to learn to walk again

01

AI Research

At ballas invest, our core belief is that focusing on AI Research, particularly in drug discovery and decentralised clinical trials, will serve as a catalyst for transforming digital health across Europe. 

 

Our conviction lies in the potential of AI to streamline the research and development process, leading to rapid, cost-effective, and targeted drug development strategies. This, is the key to unlocking new frontiers in healthcare, making advanced treatments more accessible and tailored to individual needs.

 

Our dedication extends beyond just the technological advancements; we are invested in the idea that decentralised clinical trials, empowered by AI, will democratise health research, allowing for broader participation across diverse European populations.

 

This not only ensures a more inclusive approach to clinical research but also paves the way for a more equitable healthcare landscape. 

AI in drug discovery / Decentralised trials

Doctor in a lab trying to create a vaccine

02

Patient Care

ballas invest is at the forefront of healthcare transformation across Europe by strategically investing in sectors critical to enhancing patient care — from Acute Care enhancements and Treatment Adherence to Chronic Disease Management and Geriatric Well-being. 

​

We aim at bringing to the European market technologies and methodologies that not only advance medical practices but also have a tangible impact on the lives of individuals. By fostering innovations that promote effective treatment initiation and observance, we anticipate a significant reduction in hospital readmissions and a marked improvement in chronic disease outcomes.

 

Aging well initiatives are poised to revolutionise the approach to geriatric care, enhancing the quality of life and reducing the societal and economic burdens of eldercare.

Acute care, Chronic care

Doctor taking care of an elderly person

03

AI Diagnostics

By channeling resources into AI diagnostics, we aim to bring transformative solutions to the market that enhance the accuracy, speed, and efficiency of disease detection and monitoring. Advanced AI imaging and Digital MedTech innovations are poised to redefine standard practices in medical diagnostics, offering unprecedented levels of precision and personalisation in patient care.

 

Predictive Medicine is set to pioneer proactive health management strategies, shifting the paradigm from reactive to preventative healthcare. Through these strategic investments, ballas invest envisions a future where healthcare systems are more intelligent, responsive, and tailored to individual needs.

 

We believe that by advancing these technologies, we can significantly impact lives, reducing the burden of disease, lowering healthcare costs, and ultimately leading to a healthier, more resilient population.

AI imaging, Digital MedTech

Doctor looking over some patients x-ray results

Metrics & Goals

Europe-Centric Investment Focus

  • European-based digital health startups with the potential for global impact.

  • Leverage Europe's diverse healthcare landscapes as testing grounds for scalable solutions, aiming to address both regional and worldwide health challenges.

Targeting Large Population

  • Solutions scalable across Europe's large population, aiming for widespread adoption and impact.

  • Utilise Europe’s varied demographic as a model for developing universal health solutions that can be adapted globally.

Addressing High Unmet Medical Need

  • European startups targeting areas with high unmet medical needs, setting the stage for global health improvements.

  • Solutions that not only meet the pressing health demands within Europe but also address similar needs in other parts of the world.

Inventing the Future of Healthcare

  • European startups at the forefront of innovating future healthcare paradigms with global applicability.

  • Innovations born in Europe with the potential to set new global standards in healthcare, transforming patient care and outcomes internationally.

bottom of page